Plain-English translation of NCT01566175 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing the Neovasc Coronary Sinus Reducer System, a small medical device that is placed inside a vein near your heart to help reduce severe chest pain (angina). The device is designed for people whose chest pain has not improved with medications and who are not candidates for heart surgery or other standard procedures. Researchers want to learn whether this device can safely reduce your pain and improve your quality of life.
Many patients have severe, disabling chest pain that doesn't improve even with the strongest heart medications, and they cannot have surgery or other standard treatments. This trial exists to help these patients by testing whether the new treatment can safely reduce their pain and allow them to return to normal activities.
You likely qualify if…
You likely don't qualify if…
If you are accepted into the trial, you will undergo a procedure to have the Neovasc Coronary Sinus Reducer implanted in a vein near your heart. This is done using a catheter (a thin tube) inserted through a blood vessel, similar to other heart procedures. After the implant, you will have follow-up visits to monitor your progress, check how well the device is working, and see whether your chest pain has improved and your quality of life has gotten better.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
Israel
Sponsor
Tel-Aviv Sourasky Medical Center
Collaborators
Shockwave Medical, Inc.
Enrollment target
~100 participants
Started
August 2011
Primary completion
December 2030
Age range
18 Years and older
Last updated on clinicaltrials.gov in February 2022.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Shmuel Banai, Prof.
Tel-Aviv Sourasky Medical Center
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.